Buy Blueprint Medicines Stock | BPMC Stock Price & Latest News | Public.com
BPMC

Blueprint Medicines

$0.00 (0.00%)Today
    View Blueprint Medicines (BPMC) stock trends here

    About BPMC

    Blueprint Medicines Corp. is a precision therapy company. It focuses on medicines to improve the lives of patients with genomically defined cancers, rare diseases and cancer immunotherapy. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alex...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    -1.72
    -1.72
    -1.72
    -1.72
    Q1 2021

    Expected EPS
    Q1 2021

    -$1.72

    Actual EPS
    Q1 2021

    -$1.72

    Stats

    Market Cap$5,43B
    Volume103,53k
    Price-to-Earnings Ratio16.52
    Dividend Rate
    Dividend Yield
    1 Year High$125.61
    1 Year Low$59.04
    Open$93.82
    High$95.72
    Low$93.07

    Buy any stock with any amount of money.

    Download the App
    Download the app